Open Label Clinical Trial With Rituximab (MabThera ®) in Ankylosing Spondylitis

Clinical trial NCT00432653 · UNKNOWN

Trial details

NCT number: NCT00432653
Sponsor: Charite University, Berlin, Germany
Status: UNKNOWN
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Ankylosing Spondylitis

Start date: 2007-03-01
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.